Klinger Shannon Thyme bought MRNA
June 4, 2026 · Form 4 insider transaction
Klinger Shannon Thyme bought 3,471 shares of Moderna, Inc. at $30.96 per share, a transaction worth $107.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,471
Price
$30.96
Total value
$107.5K
InsiderKlinger Shannon Thyme
Role—
CompanyModerna, Inc. (MRNA)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after70,939
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025.